Preclinical evaluation of safety and potential of black hellebore extracts for cancer treatment
Abstract Background The therapeutic use of Helleborus niger L. is manifold due to its specific phytochemical composition. Two compound groups, the ranunculin derivates including protoanemonin and the steroidal saponins, are also associated with toxicity (genotoxicity, disintegration of membrane stru...
Saved in:
Main Authors: | Jennifer E. Felenda (Author), Claudia Turek (Author), Nora Mörbt (Author), Anja Herrick (Author), Margit B. Müller (Author), Florian C. Stintzing (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of cytotoxicity, saponin, and protoanemonin contents of medicinal plant extracts from Helleborus niger L. and Helleborus foetidus L.
by: Margit B. Müller, et al.
Published: (2023) -
A Review of Clinical and Preclinical Studies on the Therapeutic Potential of Black Seeds (Nigella sativa) in the Management of Polycystic Ovarian Syndrome (PCOS)
by: Rajkapoor Balasubramanian, et al.
Published: (2023) -
Preclinical Evaluation of Esomeprazole Safety and Toxicokinetics
by: V. M. Kosman, et al.
Published: (2023) -
Anticancer Potential of Citrus Juices and Their Extracts: A Systematic Review of Both Preclinical and Clinical Studies
by: Santa Cirmi, et al.
Published: (2017) -
Preclinical Study of the Efficacy and Safety of Chondroitin Sulfate
by: E. V. Mazukina, et al.
Published: (2021)